Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tenofovir Disoproxil Fumarate Improves Outcomes Following Palliative Transarterial Chemoembolization for Hepatitis B Virus Related Hepatocellular Carcinoma

NCT01872988 is registered in ClinicalTrials.gov with Taichung Veterans General Hospital as lead sponsor.

NCT NCT01872988
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01872988 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tenofovir Disoproxil Fumarate Improves Outcomes Following Palliative Transarterial Chemoembolization for Hepatitis B Virus Related Hepatocellular Carcinoma
Lead sponsor
Taichung Veterans General Hospital
Phase
Phase 3
Overall status
Terminated
Start date
September 30, 2012
Completion date
February 28, 2018
Enrollment
320 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b, hepatocellular carcinoma